Alkali Metals Ltd
₹ 104
1.26%
23 May
11:04 a.m.
About
Incorporated in 1968, Alkali Metals Ltd is a manufacturer of Sodium Derivatives, Pyridine Derivatives, Fine Chemicals and APIs etc.[1]
Key Points
- Market Cap ₹ 105 Cr.
- Current Price ₹ 104
- High / Low ₹ 165 / 74.0
- Stock P/E
- Book Value ₹ 43.7
- Dividend Yield 0.97 %
- ROCE -4.87 %
- ROE -7.28 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 50.4%
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.05% over past five years.
- Company has a low return on equity of 0.60% over last 3 years.
- Promoters have pledged 30.1% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
66.04 | 68.44 | 73.28 | 61.12 | 64.93 | 71.56 | 70.85 | 55.38 | 91.02 | 88.23 | 82.86 | 82.33 | |
62.64 | 59.01 | 63.35 | 54.28 | 58.13 | 64.14 | 64.17 | 49.32 | 79.64 | 78.55 | 74.69 | 83.08 | |
Operating Profit | 3.40 | 9.43 | 9.93 | 6.84 | 6.80 | 7.42 | 6.68 | 6.06 | 11.38 | 9.68 | 8.17 | -0.75 |
OPM % | 5.15% | 13.78% | 13.55% | 11.19% | 10.47% | 10.37% | 9.43% | 10.94% | 12.50% | 10.97% | 9.86% | -0.91% |
0.44 | -0.35 | 0.25 | 0.12 | 0.50 | 0.40 | 0.35 | 0.05 | 0.14 | 1.05 | 0.54 | -0.74 | |
Interest | 3.49 | 4.50 | 3.44 | 2.96 | 2.52 | 2.71 | 2.47 | 2.54 | 2.63 | 2.67 | 2.56 | 2.40 |
Depreciation | 3.52 | 4.27 | 3.75 | 3.62 | 3.48 | 3.41 | 3.45 | 3.35 | 3.86 | 4.29 | 4.60 | 4.15 |
Profit before tax | -3.17 | 0.31 | 2.99 | 0.38 | 1.30 | 1.70 | 1.11 | 0.22 | 5.03 | 3.77 | 1.55 | -8.04 |
Tax % | -38.17% | 6.45% | 24.41% | 7.89% | 0.00% | 0.00% | -12.61% | 650.00% | 30.82% | 22.55% | 27.10% | -27.86% |
-1.96 | 0.28 | 2.26 | 0.35 | 1.31 | 1.69 | 1.25 | -1.21 | 3.48 | 2.91 | 1.13 | -5.80 | |
EPS in Rs | -1.92 | 0.27 | 2.22 | 0.34 | 1.29 | 1.66 | 1.23 | -1.19 | 3.42 | 2.86 | 1.11 | -5.70 |
Dividend Payout % | 0.00% | 0.00% | 54.05% | 145.43% | 77.71% | 72.28% | 81.44% | -67.31% | 58.51% | 69.97% | 90.09% | -8.78% |
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | 3% |
3 Years: | -3% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -344% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 19% |
3 Years: | 6% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | 2% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | -7% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 |
Reserves | 40.55 | 39.19 | 39.97 | 40.34 | 41.20 | 41.85 | 40.10 | 39.19 | 41.90 | 42.68 | 41.16 | 34.34 |
35.87 | 32.75 | 21.69 | 21.44 | 18.08 | 18.19 | 19.99 | 21.92 | 17.25 | 23.82 | 22.84 | 17.92 | |
14.75 | 12.47 | 15.14 | 17.55 | 19.46 | 20.81 | 16.98 | 24.96 | 27.42 | 25.24 | 31.33 | 30.50 | |
Total Liabilities | 101.35 | 94.59 | 86.98 | 89.51 | 88.92 | 91.03 | 87.25 | 96.25 | 96.75 | 101.92 | 105.51 | 92.94 |
61.06 | 57.00 | 53.71 | 49.84 | 46.82 | 44.76 | 44.87 | 46.66 | 46.27 | 49.47 | 47.29 | 41.03 | |
CWIP | 0.00 | 0.36 | 0.46 | 1.56 | 1.55 | 2.12 | 2.15 | 0.43 | 0.63 | 1.33 | 0.19 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
40.29 | 37.23 | 32.81 | 38.11 | 40.55 | 44.15 | 40.23 | 49.16 | 49.85 | 51.12 | 58.03 | 51.91 | |
Total Assets | 101.35 | 94.59 | 86.98 | 89.51 | 88.92 | 91.03 | 87.25 | 96.25 | 96.75 | 101.92 | 105.51 | 92.94 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.18 | 9.16 | 8.28 | 4.19 | 4.50 | 6.90 | 9.43 | 1.32 | 11.19 | 11.19 | 6.29 | 5.44 | |
-3.08 | -2.11 | -0.44 | -0.97 | -0.41 | -2.81 | -3.74 | -3.52 | -2.84 | -3.14 | -1.64 | -0.75 | |
2.27 | -5.53 | -9.92 | -3.26 | -4.06 | -4.08 | -3.16 | 0.07 | -6.82 | -8.96 | -5.71 | -4.69 | |
Net Cash Flow | 0.37 | 1.52 | -2.08 | -0.05 | 0.03 | 0.02 | 2.53 | -2.13 | 1.53 | -0.91 | -1.06 | 0.00 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 74.72 | 45.65 | 56.28 | 61.39 | 79.26 | 54.78 | 32.82 | 79.02 | 53.74 | 56.63 | 79.16 | 63.57 |
Inventory Days | 139.35 | 176.18 | 119.11 | 251.90 | 194.18 | 241.56 | 233.58 | 493.80 | 245.90 | 277.93 | 381.69 | 223.28 |
Days Payable | 134.00 | 111.92 | 116.85 | 182.90 | 166.75 | 169.77 | 121.63 | 318.70 | 165.04 | 180.30 | 281.00 | 161.04 |
Cash Conversion Cycle | 80.07 | 109.91 | 58.55 | 130.39 | 106.70 | 126.57 | 144.76 | 254.13 | 134.59 | 154.26 | 179.84 | 125.82 |
Working Capital Days | 105.34 | 86.08 | 65.25 | 98.71 | 99.84 | 102.57 | 90.10 | 166.88 | 86.74 | 97.71 | 113.74 | 79.85 |
ROCE % | 0.36% | 6.97% | 8.35% | 5.05% | 5.47% | 6.31% | 5.41% | 4.10% | 11.11% | 8.94% | 5.99% | -4.87% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - In continuation to our Announcement dated 19th May 2025, copies of Paper Ad pertaining to Results is enclosed.
- Full Results 19 May
-
Board Meeting Outcome for Outcome Of The Board Meeting
19 May - Audited FY25 results with Rs 0.50 dividend; new secretarial and internal auditors appointed.
-
Board Meeting Intimation for Approval Audited Financial Statements And Results For The Period / Quarter Ended 31St March 2025 And Other Business Items.
12 May - Board meeting on 19 May 2025 to approve FY25 audited results and consider dividend.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
16 Apr - Certificate Under Regulation 74 of SEBI (DP) Regulations for the quarter ended 31st March 2025 issued by RTA of the Company.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
AML, originally a joint venture with Andhra Pradesh Industrial Development Corporation Limited (APIDCL), is now an ISO 9001 & 14001-certified manufacturer specializing in sodium metal derivatives, picoline-based compounds, and cyclic chemicals. Its key products include sodium amide, sodium azide, sodium hydride, amino pyridines, fine chemicals, and APIs, primarily supplied to pharmaceutical companies for bulk drug production